In a ruling that may portend a major uptick in False Statements Act (FCA) whistleblower circumstances, past week the U.S. Court of Appeals for the District of Columbia Circuit reversed a 2018 decision that vacated Medicare’s “Overpayment Rule” for Medicare Advantage organizations (MAOs). As a consequence, CMS can once once more impose obligations on MAOs to proactively return determined overpayments in 60 days. We discuss UnitedHealth v. Becerra and its most likely influence under.
The Overpayment Rule
Adopted in 2014 as part of the Cost-effective Treatment Act, the Overpayment Rule demands MAOs to report and return any overpayment inside of 60 times right after the payment is “identified.” An overpayment is “identified” when the MAO “has established, or must have established by the exercising of realistic diligence” that the MAO acquired an overpayment. UnitedHealth challenged this rule in January 2016, arguing that it improperly decreased the FCA’s well-founded “knowingly” expertise common to a single of mere negligence. UnitedHealth also argued that the Overpayment Rule violated the statutory requirement of “actuarial equivalence,” which, broadly talking, is intended to make sure that Medicare Benefit suppliers receive equivalent pay for expert services as as opposed to their classic fee-for-support Medicare counterparts.
The D.C. District Court docket agreed with UnitedHealth’s argument in equally respects, holding that the Overpayment Rule not only conflicted with the FCA’s know-how necessity, but also violated actuarial equivalence in that it imposed reimbursement obligations on Medicare Edge suppliers that were being not imposed on traditional Medicare providers. The court reasoned that although payments under standard Medicare and Medicare Edge are the two set yearly primarily based on expenses from unaudited Medicare information, only Medicare Edge insurers are essential to return overpayments centered on audited individual records. This, in accordance to the district court docket, systemically devalues payments to Medicare Advantage insurers in violation of the Medicare statute.
Circuit Court docket Ruling
On appeal, the D.C. Circuit overruled the decrease courtroom, concluding that the Overpayment Rule “does not violate, or even implicate, actuarial equivalence”. Hunting to the building and logic of the Rule, the court reasoned that “[t]he actuarial-equivalence necessity and the overpayment-refund obligation apply to diverse actors, focus on distinct challenges arising at distinct instances, and work at different degrees of generality.” In that context, the courtroom pointed out that the Medicare legislation only directs CMS to reimburse Medicare Gain plans at approximately the similar premiums as common Medicare companies it does not refer to the overpayment obligation. The court docket also mentioned that even if actuarial equivalence did implicate the Overpayment Rule, UnitedHealth did not right problem CMS’ risk adjustment model, nor did it present proof that the design resulted in unequal payments concerning Medicare and Medicare Benefit providers.
“Even if actuarial equivalence utilized as UnitedHealth implies, it would be UnitedHealth’s stress to clearly show the systematically skewed inaccuracies on which its principle depends, which it has not accomplished. Also fatal to UnitedHealth’s claim is that it by no means challenged the values CMS assigned to the possibility things it recognized or the degree of the capitation payments ensuing from CMS’s chance-adjustment model… It are unable to belatedly do so in the guise of a challenge to the Overpayment Rule.”
This ruling unquestionably contributes to the now heightened chance atmosphere struggling with MAOs – a development introduced into unique focus previous December when Deputy Assistant Legal professional Basic Michael Granston singled out Medicare Advantage fraud as an “important priority” for DOJ enforcement shifting ahead. That reported, it is noteworthy that CMS elected not to charm the district court’s getting that the Overpayment Rule properly imposed an impermissible negligence typical in specific FCA instances. As this kind of, the D.C. Circuit did not straight rule on irrespective of whether, shifting forward, CMS can mandate that MAOs engage in proactive self-auditing or other “reasonable diligence” in get to comply with the Overpayment Rule. On the other hand, the court docket did remark:
“Nothing in the Overpayment Rule obligates insurers to audit their described data. As the district court docket held… the Rule only necessitates insurers to refund quantities they know ended up overpayments, i.e., payments they are aware deficiency guidance in a beneficiary’s medical records. That restricted scope does not impose a self-auditing mandate.”
Whilst the court’s feedback ended up fairly gratuitous, they raise the issue of whether or not they might undermine DOJ’s current situation in other noteworthy pending matters. For case in point, just weeks back the government intervened in 6 grievances against the Kaiser Permanente consortium, and the Anthem fit stays pending in the Southern District of New York. Both equally of these issues are premised on the principle that MAOs have an obligation to proactively audit their information just before distributing to Medicare – significantly on “red flag” codes and when they are in risk-sharing agreements that give providers an incentive to overcode. It is essential that MAOs operating in this ecosystem continue to be mindful of the hazard around their coding and billing practices. This is specifically correct for audit and monitoring capabilities, given the latest intense uptick in “one-way auditing” qui tams, and the actuality that courts across the place have not universally agreed with the D.C. District Court’s feeling of the impact of the Overpayment Rule on FCA scienter.
© 2021 Bradley Arant Boult Cummings LLPNationwide Law Evaluation, Quantity XI, Quantity 239